News | Artificial Intelligence | April 02, 2019 | Jeff Zagoudis, Associate Editor

FDA Proposes New Review Framework for AI-based Medical Devices

Discussion paper describes need to regulate artificial intelligence that continuously learns

FDA Proposes New Review Framework for AI-based Medical Devices

April 2, 2019 — U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D., announced Tuesday the agency is pursuing a new framework in which to review artificial intelligence (AI)-based medical software and devices to ensure ongoing effectiveness and patient safety. The agency released a 20-page discussion paper explaining the need for a new framework, the tenets of a total product lifecycle (TPLC) approach to certification, and examples of potential real-world AI software modifications that may or may not be permitted under the proposed framework. The FDA is asking for comments and feedback from all parties to inform future decisions.

Locked Versus Adaptive AI

To date, only two AI-based technologies have received full FDA approval and are in clinical use — IDx-DR, a software that detects diabetic retinopathy, and the Viz.AI Contact application that analyzes computed tomography (CT) images for potential signs of stroke. Gottlieb noted that both of these technologies can be considered “locked” algorithms. This means that the base algorithms can only be modified by the manufacturer, and must be manually verified and validated by them as well. Other AI algorithms are considered “adaptive” or “continuously learning,” and these learn from new user data acquired through real-world use.

In the statement, Gottlieb acknowledged the vast potential of such adaptive algorithms, but also insisted that these more open technologies must still adhere to the FDA’s safety and effectiveness standards.

Total Product Lifecycle Regulatory Approach

The discussion paper describes how the current 510(k) approval pathway takes a risk-based approach, requiring new premarket submissions for some software modifications. Categories of software modifications that may require a premarket submission include:

  • A change that introduces a new risk or modifies an existing risk that could result in significant harm;
  • A change to risk controls to prevent significant harm; and
  • A change that significantly affects clinical functionality or performance specifications of the device.

For today’s AI-based technologies, the discussion paper notes these considerations must be balanced with the ability for the software to “continue to learn and evolve over time to improve patient care.”

To satisfy all of these requirements, the discussion paper explores the potential of a total product lifecycle (TPLC)-based approach to certification. In this model, the FDA would “assess the culture of quality and organizational excellence of a particular company, and have reasonable assurance of the high quality of their software development, testing and performance monitoring of their products.”

One of the key elements considered in the TPLC approach will be a software’s predetermined change control plan. This plan would provide detailed information about the types of anticipated modifications based on the algorithm’s re-training and update strategy, and the associated methodology being used to implement those changes in a controlled manner that manages risks to patients. According to Gottlieb, the goal of a revised framework would to assure that ongoing algorithm changes:

  • Follow pre-specified performance objectives and change control plans;
  • Use a validation process that ensures improvements to the performance, safety and effectiveness of the AI software; and
  • Include real-world monitoring of performance once the device is on the market to ensure safety and effectiveness are maintained.

The agency is taking public comment on the contents of the discussion paper through June 3, 2019. The full discussion paper can be read here. Comments can be submitted here.

For more information: www.fda.gov

Related Content

Sectra Signs Enterprise Imaging Contract With Vanderbilt Health
News | Enterprise Imaging | August 21, 2019
Sectra will install its enterprise imaging picture archiving and communication system (PACS) and vendor neutral archive...
Videos | Treatment Planning | August 21, 2019
This is an example of the Mirada DLCExpert deep learning software that automatically identifies organs, segments and
News | Cybersecurity | August 20, 2019
Healthcare data breaches are currently being reported at a rate of more than one a day, according to a new report from...
Lunit Receives Korea MFDS Approval for Lunit Insight MMG
News | Artificial Intelligence | August 19, 2019
Lunit has announced Korea Ministry of Food and Drug Safety (MFDS) approval of its artificial intelligence (AI) solution...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...
The CT scanner might not come with protocols that are adequate for each hospital situation, so at Phoenix Children’s Hospital they designed their own protocols, said Dianna Bardo, M.D., director of body MR and co-director of the 3D Innovation Lab at Phoenix Children’s.

The CT scanner might not come with protocols that are adequate for each hospital situation, so at Phoenix Children’s Hospital they designed their own protocols, said Dianna Bardo, M.D., director of body MR and co-director of the 3D Innovation Lab at Phoenix Children’s.

Sponsored Content | Case Study | Radiation Dose Management | August 13, 2019
Radiation dose management is central to child patient safety. Medical imaging plays an increasing role in the accurate...
Lake Medical Imaging Selects Infinitt for Multi-site RIS/PACS
News | PACS | August 09, 2019
Infinitt North America will be implementing Infinitt RIS (radiology information system)/PACS (picture archiving and...
Half of Hospital Decision Makers Plan to Invest in AI by 2021
News | Artificial Intelligence | August 08, 2019
August 8, 2019 — A recent study conducted by Olive AI explores how hospital leaders are responding to the imperative
NetDirector Launches Cloud-based PDF to DICOM Conversion Service
News | PACS | August 08, 2019
NetDirector, a cloud-based data exchange and integration platform, has diversified their radiology automation options...
ScImage Introduces PICOM ModalityGuard for Cybersecurity
Technology | Cybersecurity | August 07, 2019
ScImage Inc. is bridging the gap between security and functionality with the introduction of the PICOM ModalityGuard....